Utility of the dual antiplatelet therapy score to guide antiplatelet therapy: A systematic review and meta‐analysis-Reference-Cited by-同舟云学术

Utility of the dual antiplatelet therapy score to guide antiplatelet therapy: A systematic review and meta‐analysis

Published:2020-10-28 Issue:4 Volume:97 Page:569-578
ISSN:1522-1946
Container-title:Catheterization and Cardiovascular Interventions
language:en
Short-container-title:Catheter Cardiovasc Interv

Author:

Mihatov Nino¹²^ORCID,Secemsky Eric A.¹,Kereiakes Dean J.³,Steg Gabriel⁴,Serruys Patrick W.⁵^ORCID,Chichareon Ply⁶⁷,Shen Changyu¹,Yeh Robert W.¹

Affiliation:

1. Richard A. and Susan F. Smith Center for Outcomes Research Beth Israel Deaconess Medical Center, Harvard Medical School Boston Massachusetts USA

2. Division of Cardiology, Department of Medicine Massachusetts General Hospital, Harvard Medical School Boston Massachusetts USA

3. The Christ Hospital Heart and Vascular Center, The Lindner Research Center Cincinnati Ohio USA

4. Université Paris‐Diderot, Hôpital Bichat, Assistance Publique–Hôpitaux de Paris, INSERM U‐1148, FACT (French Alliance for Cardiovascular Trials) Paris France

5. Department of Cardiology, National University of Ireland, Galway (NUIG), Galway, Ireland; National Heart and Lung Institute, Imperial College London UK

6. Amsterdam UMC, University of Amsterdam, Heart Center; Department of Clinical and Experimental Cardiology, Amsterdam Cardiovascular Sciences Amsterdam The Netherlands

7. Division of Cardiology, Department of Internal Medicine, Faculty of Medicine Prince of Songkla University Songkhla Thailand

Funder

National Heart, Lung, and Blood Institute

National Institutes of Health

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Radiology Nuclear Medicine and imaging,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ccd.29352

Reference38 articles.

1. 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes, and 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery

2. Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents

3. Long‐term dual antiplatelet therapy for secondary prevention of cardiovascular events in the subgroup of patients with previous myocardial infarction: a collaborative meta‐analysis of randomized trials;Udell JA;Eur Heart J,2016

4. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS

5. Six months versus 12 months dual antiplatelet therapy after drug-eluting stent implantation in ST-elevation myocardial infarction (DAPT-STEMI): randomised, multicentre, non-inferiority trial

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Updates in Coronary Artery Disease: A Comprehensive Review;Journal of Clinical Medicine;2024-08-06

2. One-Month Duration Compared with Twelve-Month Duration of Dual Antiplatelet Therapy in Elective Angioplasty for Coronary Artery Disease: Bleeding and Ischaemic Outcomes;Journal of Clinical Medicine;2024-08-02

3. Associations Between Dual Antiplatelet Therapy Score and Long-Term Mortality After Percutaneous Coronary Intervention: Analysis of More Than 27,000 Patients;Canadian Journal of Cardiology;2024-07

4. A Practical Nomogram for Predicting the Bleeding Risk in Patients with a History of Myocardial Infarction Treating with Aspirin;Clinical and Applied Thrombosis/Hemostasis;2024-01

5. Finding a Constrained Number of Predictor Phenotypes for Multiple Outcome Prediction;2024